dpd_mnk92
Bluelighter
- Joined
- Jun 5, 2012
- Messages
- 181
Hi all,
I am a 20 year old male that has recently destroyed his brain during a disgusting MDMA binge (1.5 grams over the course of a few hours). Unfortunately, I wasn't even aware that I was continuing to consume the stuff past the 0.5 mark and had no friends around to stop me at the time. I have more than learnt my lesson (to not have lots of drugs on me at any point in time because i'm an unreliable c***) and I'm still dealing with the symtoms a month on, which include: depression, anxiety, HPPD, mild DR, sleeping problems, memory problems and severe decline in general cognitive ability (particularly spoken verbal fluency).
My doctor has prescribed me a relatively new anti-depressant called agomelatine (Valdoxan) in the hope that it might deal with some of these symptoms (sleeping problems, anxiety + depression) but I wanted to first double-check on here to get some second opinions on whether or not I should be putting this stuff into my body at a time when my brain is recovering/ rewiring itself after the damage that has occurred. I know you guys probably won't have any definitive answers based on the fact that it is a relatively new type of medication and that very few people have been in this situation before, but I was hoping some of you dudes in the advanced drug discussion forum might be able to draw some conclusions based on its mechanism of action. In short, I would very much like to start this medication to help deal with some of my problems but I am hesitant as I have no idea whether or not it would interfere with my recovery. Obviously, the long-term goal is to reverse as much of the damage caused as possible...
Any ideas, whether right or wrong, would be seriously appreciated right now!!
From wikipedia --> Mechanism of action
Agomelatine is a melatonergic agonist (MT1 (Ki=0.10nM±0.01nM) and MT2 receptors (Ki=0.12nM±0.02nM)) and 5-HT2C antagonist (IC50=270nM; pKi=6.15±0.04). Binding studies indicate that it has no effect on monoamine uptake and no affinity for adrenergic, histaminergic, cholinergic, dopaminergic and benzodiazepine receptors, nor other serotonergic receptors.[2]
I am a 20 year old male that has recently destroyed his brain during a disgusting MDMA binge (1.5 grams over the course of a few hours). Unfortunately, I wasn't even aware that I was continuing to consume the stuff past the 0.5 mark and had no friends around to stop me at the time. I have more than learnt my lesson (to not have lots of drugs on me at any point in time because i'm an unreliable c***) and I'm still dealing with the symtoms a month on, which include: depression, anxiety, HPPD, mild DR, sleeping problems, memory problems and severe decline in general cognitive ability (particularly spoken verbal fluency).
My doctor has prescribed me a relatively new anti-depressant called agomelatine (Valdoxan) in the hope that it might deal with some of these symptoms (sleeping problems, anxiety + depression) but I wanted to first double-check on here to get some second opinions on whether or not I should be putting this stuff into my body at a time when my brain is recovering/ rewiring itself after the damage that has occurred. I know you guys probably won't have any definitive answers based on the fact that it is a relatively new type of medication and that very few people have been in this situation before, but I was hoping some of you dudes in the advanced drug discussion forum might be able to draw some conclusions based on its mechanism of action. In short, I would very much like to start this medication to help deal with some of my problems but I am hesitant as I have no idea whether or not it would interfere with my recovery. Obviously, the long-term goal is to reverse as much of the damage caused as possible...
Any ideas, whether right or wrong, would be seriously appreciated right now!!
From wikipedia --> Mechanism of action
Agomelatine is a melatonergic agonist (MT1 (Ki=0.10nM±0.01nM) and MT2 receptors (Ki=0.12nM±0.02nM)) and 5-HT2C antagonist (IC50=270nM; pKi=6.15±0.04). Binding studies indicate that it has no effect on monoamine uptake and no affinity for adrenergic, histaminergic, cholinergic, dopaminergic and benzodiazepine receptors, nor other serotonergic receptors.[2]